Biomedical Scientists Benefit NHS Up to £571M in Bowel Cancer Care
A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists,...
The NHS category focuses on the people, policies and challenges shaping the UK’s publicly funded health service. It offers thoughtful analysis of organisational change, workforce issues, funding and performance, along with debate on how to improve care delivery and health outcomes. From insights into frontline practice to discussion of strategic priorities and reforms, this category brings clarity to the complex forces influencing the future of health and care in the NHS.